Skip to main content
OpenTrials

Clinical trial condition

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Explore clinical trials studying Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Study availability and eligibility vary by location and protocol.

82 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis trial results

Completed

FASENRA Regulatory Postmarketing Surveillance in Korea

NCT05091333

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Asthma, Asthma, EGPA(Eosinophilic Granulomatosis With Polyangiitis), +21 more
Locations
  • Research Site Busan, South Korea
  • Research Site Gangneung-si, South Korea
  • Research Site Seoul, South Korea
  • Research Site Suwon, South Korea
View Trial Details
Completed

Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis

NCT03482479

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Arch Syndromes, Aortic Diseases, +33 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions